Blog

CTD stands for Common Technical Document. Think of it as the universal passport for getting your drug approved — one standardized format accepted by regulators in the US, Europe, and Japan. Before the CTD existed, every country wanted information organized differently. Companies were stuck redoing the same work for every market. It was expensive, slow, […]

Pharmaceutical market research is not just about data. It is about decoding reality. You are not studying numbers. You are studying patients, physicians, regulators, and markets that behave differently across regions and therapies. After more than a decade of working with global pharma companies, one pattern stands out: most failures are not due to lack […]

Where you build your pharmaceutical plant is not just a real estate decision. It is one of the most important strategic choices your company will ever make. The right location can cut your costs, speed up your regulatory approvals, and give you access to the best talent in the industry. The wrong location? It can […]

Getting a drug approved in India sounds simple on paper. In reality, it’s anything but. Many companies spend millions, follow the science, and still end up stuck in delays or outright rejection. Not because the drug is bad, but because the process is strict, detailed, and easy to mess up. India’s drug approval system leaves […]

When your drug is going through approval process, there are a lot of documents that you need to prepare. Different countries have different needs, each doc holds utmost importance. One small formatting error can put you back to square one. Therefore, common technical documents come in handy. If you are in pharmaceutical development, you need […]

Europe is one of the strictest pharma markets, but also one of the best places to launch a new drug. Companies love the market size, but they also know the rules here can feel… well, a bit confusing. In Europe, drug approval does not happen through just one office. You have EMA, you have national […]

Bringing a medicine to the European market isn’t just a regulatory exercise—it’s an endurance game. A long one. The kind where preparation matters more than speed, and small mistakes quietly add months to your timeline. The Centralized Procedure (CP) is the big, shiny route everyone wants because one approval opens the doors to all EU […]

Choosing the right site for your pharma or biotech facility isn’t just about cheap land. It’s about smart, long-term decisions that affect your growth, compliance, and costs. Here’s a simple, step-by-step snapshot of the process: Step What it involves Preliminary Research Gather data on possible locations, infrastructure, and proximity to suppliers and customers. Internal Needs […]

The lifesciences world is changing fast. What used to take years of guesswork and paperwork is now powered by data, AI, and the cloud. From discovering new drugs to running clinical trials, digital tools are cutting down time, cost, and confusion. But not everyone’s caught up. Some companies still do things the old-school way — […]

Buying chemicals the old way is slow, messy, and stressful. Long negotiations, unclear pricing, and uncertain lead times make procurement a headache. One missed detail can delay production or spike costs. Enter the online B2B chemical marketplace. These digital platforms cut through the chaos by giving you real-time inventory, instant pricing, and verified suppliers at […]